Relay Therapeutics, Inc.
NASDAQ:RLAY
3 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.679 | 0 | 0 | 0 | 10.007 | -0.001 | 25.202 | 0.119 | 0.226 | 0.253 | 0.344 | 0.365 | 0.419 | 0.567 | 0.666 | 0.844 | 0.952 | 82.654 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 7.244 | 0 | 1.368 | 1.395 | 1.375 | 1.363 | 1.334 | 1.197 | 1.166 | 1.033 | 60.511 | 0.975 | 1.034 | 44.155 | 45.147 | 30.622 | 67.739 | 24.376 | 21.666 | 21.7 | 0 | 0 | 0 | 0 |
| Gross Profit
| 7.679 | -7.244 | 0 | -1.368 | 8.612 | -1.376 | 23.839 | -1.215 | -0.971 | -0.913 | -0.689 | -60.146 | -0.556 | -0.467 | -43.489 | -44.303 | -29.67 | 14.915 | -24.376 | -21.666 | -21.7 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0 | 0 | 0 | 0.861 | 1,376 | 0.946 | -10.21 | -4.296 | -3.609 | -2.003 | -164.784 | -1.327 | -0.824 | -65.299 | -52.492 | -31.166 | 0.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 73.809 | 68.075 | 76.619 | 91.992 | 82.403 | 77.496 | 81.494 | 88.201 | 82.827 | 67.277 | 66.9 | 60.511 | 51.667 | 51.907 | 44.974 | 45.147 | 30.622 | 32.123 | 24.376 | 21.666 | 21.7 | 22.407 | 18.256 | 16.397 | 13.335 |
| General & Administrative Expenses
| 18.739 | 16.904 | 19.75 | 20.139 | 19.799 | 16.766 | 18.485 | 20.12 | 19.579 | 16.371 | 16.074 | 17.465 | 16.068 | 15.547 | 14.682 | 14.422 | 12.735 | 15.543 | 12.231 | 6.053 | 4.758 | 3.426 | 3.652 | 3.508 | 3.067 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -1.368 | -1.395 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.739 | 16.904 | 19.75 | 18.771 | 18.404 | 16.766 | 18.485 | 20.12 | 19.579 | 16.371 | 16.074 | 17.465 | 16.068 | 15.547 | 14.682 | 14.422 | 12.735 | 15.543 | 12.231 | 6.053 | 4.758 | 3.426 | 3.652 | 3.508 | 3.067 |
| Other Expenses
| 0 | 0 | 0 | -0.002 | 0.025 | 0.001 | -0.002 | -0.014 | -0.003 | -0.024 | 0.007 | 0.018 | -0.021 | 0 | 2 | 0.001 | -0.005 | -0.008 | -0.005 | -0.003 | 0 | 0 | -0.001 | 0 | -0.057 |
| Operating Expenses
| 92.548 | 84.979 | 96.369 | 110.763 | 100.807 | 94.262 | 99.979 | 108.321 | 102.406 | 83.648 | 82.974 | 77.976 | 67.735 | 67.454 | 59.656 | 59.569 | 43.357 | 47.666 | 36.607 | 27.719 | 26.458 | 25.833 | 21.908 | 19.905 | 16.402 |
| Operating Income
| -84.869 | -84.979 | -96.369 | -112.131 | -92.195 | -92.196 | -73.577 | -106.05 | -101.177 | -72.851 | -85.892 | -77.811 | -62.721 | -67.456 | -60.99 | -193.58 | -42.405 | 34.988 | -36.607 | -27.719 | -26.458 | -25.833 | -21.908 | -19.905 | -16.402 |
| Operating Income Ratio
| -11.052 | 0 | 0 | 0 | -9.213 | 92,196 | -2.919 | -891.176 | -447.686 | -287.949 | -249.686 | -213.181 | -149.692 | -118.97 | -91.577 | -229.36 | -44.543 | 0.423 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 7.804 | 8.975 | 8.264 | 8.545 | 8.976 | 8.701 | 7.843 | 7.545 | 6.938 | 5.348 | 1.72 | 1.023 | 0.675 | 0.267 | 0.157 | 0.181 | 0.221 | 0.288 | 0.529 | 0.995 | 1.572 | 1.92 | 2.235 | 2.368 | 2.22 |
| Income Before Tax
| -77.065 | -76.004 | -88.105 | -92.212 | -81.387 | -83.495 | -65.734 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 | -62.046 | -67.456 | -60.833 | -193.399 | -42.184 | 35.276 | -36.078 | -26.724 | -24.886 | -23.913 | -19.673 | -17.537 | -14.182 |
| Income Before Tax Ratio
| -10.036 | 0 | 0 | 0 | -8.133 | 83,495 | -2.608 | -827.773 | -416.987 | -266.81 | -244.686 | -210.378 | -148.081 | -118.97 | -91.341 | -229.146 | -44.311 | 0.427 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 1.352 | 18.012 | -1.363 | -9.711 | -6.938 | -24.188 | 3.091 | -0.805 | -10.561 | -0.836 | 0.157 | 0.181 | 0.221 | 0.288 | 0.529 | 0.995 | 1.572 | 1.92 | 2.235 | 2.368 | 2.22 |
| Net Income
| -77.065 | -76.004 | -88.105 | -92.212 | -81.387 | -83.495 | -65.734 | -98.505 | -87.301 | -43.315 | -87.263 | -76.788 | -51.485 | -67.456 | -60.833 | -193.399 | -42.184 | 35.276 | -36.078 | -26.724 | -24.886 | -23.913 | -19.673 | -17.537 | -14.182 |
| Net Income Ratio
| -10.036 | 0 | 0 | 0 | -8.133 | 83,495 | -2.608 | -827.773 | -386.288 | -171.206 | -253.672 | -210.378 | -122.876 | -118.97 | -91.341 | -229.146 | -44.311 | 0.427 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.1 | -0.47 | 0.5 | -0.51 | -6.06 | -5.99 | -6.24 | -5.53 | -5.28 | -4.59 |
| EPS Diluted
| -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.1 | -0.47 | 0.5 | -0.51 | -6.06 | -5.99 | -6.24 | -5.53 | -5.28 | -4.59 |
| EBITDA
| -84.869 | -81.486 | -95.002 | -110.763 | -90.8 | -92.888 | -73.414 | -106.868 | -100.983 | -82.229 | -81.597 | -76.655 | -66.341 | -66.422 | -57.978 | -57.765 | -41.486 | 36.188 | -35.694 | -26.854 | -25.599 | -24.98 | -21.274 | -19.214 | -15.735 |
| EBITDA Ratio
| -11.052 | 0 | 0 | 0 | -9.074 | 92,888 | -2.913 | -898.05 | -446.827 | -325.016 | -237.201 | -210.014 | -158.332 | -117.146 | -87.054 | -68.442 | -43.578 | 0.438 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |